The Multiple System Atrophy Trust is the UK and Ireland's only charity dedicated to providing specialist support to all those affected by MSA; a life-limiting neurodegenerative brain disease. We rely entirely on voluntary donations to provide our free support services. ...
CB is supported by the Multiple System Atrophy Trust, the British Neuropathological Society, and an Alzheimer's Research UK Research Fellowship. JLH is supported by the Multiple System Atrophy Trust; the Multiple System Atrophy Coalition; Fund Sophia, managed by the King Baudouin Foundation and ...
Synucleinopathies, which include multiple system atrophy (MSA), Parkinson’s disease, Parkinson’s disease with dementia and dementia with Lewy bodies (DLB), are human neurodegenerative diseases1. Existing treatments are at best symptomatic. These diseases are characterized by the presence of, and be...
This work was funded by a grant entitled "The role of CoQ2 in multiple system atrophy"–in memory of Elaine Bache, supported by the MSA Trust. The authors are also grateful to the MSA Coalition, the Medical Research Council UK (MR/J004758/1), the Wellcome Trust (WT...
 There is currently no cure for Multiple System Atrophy; The lack of awareness about Multiple System Atrophy has hindered research and the ability of researchers to obtain funding for their work;  Public support and greater awareness of the need for research funding can aid in the discove...
similar to the glial cytoplasmic inclusions of multiple system atrophy (MSA). Both inclusion types were ubiquitin and p62 positive and were labelled with phosphorylation-dependent anti-α-synuclein antibodies In addition, TDP-43 immunoreactive inclusions were observed in limbic regions and in the ...
The multiple sclerosis condition center is a resource for clinical news on the diagnosis, treatment, and management of multiple sclerosis. | NeurologyLive.
1). The NAWM-led subtype was characterised by an early reduction in the T1/T2 ratio of the cingulate bundle and corpus callosum, followed by a reduction in T1/T2 ratio in the cerebellar, temporal and parietal NAWM, atrophy of the occipital cortex, T2 lesion accrual, and, in the late ...
, m. ukmar , r.s. pozzi-mucelli , et al. effects of iv methylprednisolone on brain atrophy in relapsing-remitting ms neurology , 57 ( 7 ) ( 2001 ) , pp. 1239 - 1247 m. zouali b lymphocytes–chief players and therapeutic targets in autoimmune diseases front. biosci. , 13 ( ...
The excluded rare brain diseases included frontotemporal lobar degeneration (FTLD), chronic traumatic encephalopathy, multiple sclerosis, multiple system atrophy, amyotrophic lateral sclerosis, triplet repeat (e.g., Huntington's and other) diseases, and prion diseases. These exclusions involved removing 98...